Tumor necrosis factor-? promotes atherosclerotic lesion progression in APOE*3-leiden transgenic mice
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Tumor necrosis factor-alpha (TNFalpha) is a pleiotropic cytokine exerting both inflammatory and cell death modulatory activity, and is thought to play a role in the pathogenesis of atherosclerosis. Studies in mice indicated that TNFalpha affects atherosclerosis minimally or not under conditions that allow fatty streak formation. Here, we examined the possible role of TNFalpha in advanced and complex atherosclerotic lesions. METHODS AND RESULTS: To induce atherosclerosis, TNFalpha-deficient (Tnf-/-) APOE*3-Leiden and control APOE*3-Leiden only mice were fed a cholesterol-rich diet. Comparable levels of plasma cholesterol and triglycerides and the systemic inflammatory parameters, serum amyloid A and soluble intercellular adhesion molecule-1 were found in APOE*3-LeidenTnf-/- and control mice. Although absence of TNFalpha did not affect the quantitative area of atherosclerosis, APOE*3-LeidenTnf-/- mice had a higher relative number of early lesions (46.1% vs. 21.4%) and a lower relative number of advanced lesions (53.9% vs. 78.6%, P=0.04). In addition, the advanced lesions in APOE*3-LeidenTnf-/- mice showed less necrosis (9.9+/-12.1% vs. 23.4+/-19.3% of total lesion area, P=0.04) and an increase in apoptosis (1.5+/-1.5% vs. 0.4+/-0.6% of total nuclei, P=0.03). CONCLUSIONS: Our data indicate that TNFalpha stimulates the formation of lesions towards an advanced phenotype, with more lesion necrosis and a lower incidence of apoptosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Protection from obesity-induced insulin resistance in mice lacking TNF-α function
Uysal, K. T., Wiesbrock, S. M., Marino, M. W., & Hotamisligil, G. S. (1997) · Nature · doi:10.1038/39335 · Cited by 2,234 · cited 1×
“demonstrated that the total weight gain in obese Tnf+/+ mice on a high fat diet was larger than that of obese Tnf / mice, which was related to a decrease in fatpad weight [45].”
BackgroundPfeffer, K., Matsuyama, T., Kündig, T. M., Wakeham, A., Kishihara, K., Shahinian, A., Wiegmann, K., Ohashi, P. S., Krönke, M., & Mak, T. W. (1993) · Cell · doi:10.1016/0092-8674(93)90134-c · Cited by 1,677 · cited 2×
“Whereas binding of TNFa to TNFR1 activates responses associated with induction of adhesion molecule expression [5], apoptosis [6], and resistance to bacterial infection [7,8], binding to TNFR2 activates induction of T cell proliferation 66 (2005) 179–185”
BackgroundHavekes, L., de Wit, E., Leuven, J. G., Klasen, E., Utermann, W., Weber, W., & Beisiegel, U. (1986) · Human Genetics · doi:10.1007/bf00291607 · Cited by 99 · cited 1×
“Family studies have demonstrated that this mutation is associated with a dominantly inherited form of familial dysbetalipoproteinemia (FD) [23–25].”
BackgroundSelf-citationWardell, M. R., Weisgraber, K. H., Havekes, L. M., & Rall, S. C. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)30067-5 · Cited by 80 · cited 1×
“Family studies have demonstrated that this mutation is associated with a dominantly inherited form of familial dysbetalipoproteinemia (FD) [23–25].”
BackgroundSelf-citationApolipoprotein E*3-Leiden allele results from a partial gene duplication in exon 4
van den Maagdenberg, A. M. J. M., de Knijff, P., Stalenhoef, A. F. H., Gevers Leuven, J. A., Havekes, L. M., & Frants, R. R. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(89)80044-0 · Cited by 57
Self-citation
Cited by
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Tedgui, A., & Mallat, Z. (2006) · Physiological Reviews · doi:10.1152/physrev.00024.2005 · Cited by 1,701
Emerging Roles of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and Cancer
Kong, D.-H., Kim, Y., Kim, M., Jang, J., & Lee, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041057 · Cited by 683
Cytokines and atherosclerosis: a comprehensive review of studies in mice
Kleemann, R., Zadelaar, S., & Kooistra, T. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn120 · Cited by 606
Adipokines: A link between obesity and cardiovascular disease
Nakamura, K., Fuster, J. J., & Walsh, K. (2014) · Journal of Cardiology · doi:10.1016/j.jjcc.2013.11.006 · Cited by 578
Interactions between Roseburia intestinalis and diet modulate atherogenesis in a murine model
Kasahara, K., Krautkramer, K. A., Org, E., Romano, K. A., Kerby, R. L., Vivas, E. I., Mehrabian, M., Denu, J. M., Bäckhed, F., Lusis, A. J., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0272-x · Cited by 538
Metadata
- Authors
- BOESTEN, L., ZADELAAR, A., VANNIEUWKOOP, A., GIJBELS, M., DEWINTHER, M., HAVEKES, L., & VANVLIJMEN, B.
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-04-01
- Volume
- 66
- Issue
- 1
- Pages
- 179-185
- ISSN
- 0008-6363 (ISSN-L)
- OpenAlex
- W2123329109
- Cited by
- 116
- References
- 5
- FWCI
- 2.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tumor necrosis factor-? promotes atherosclerotic lesion progression in APOE*3-leiden transgenic mice. https://app.cochat.ai/papers/10.1016/j.cardiores.2005.01.001
- The paper
- BOESTEN, L., ZADELAAR, A., VANNIEUWKOOP, A., GIJBELS, M., DEWINTHER, M., HAVEKES, L., & VANVLIJMEN, B. (2005). Tumor necrosis factor-? promotes atherosclerotic lesion progression in APOE*3-leiden transgenic mice. Cardiovascular Research. https://doi.org/10.1016/j.cardiores.2005.01.001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.